Amneal Pharmaceuticals Inc
NYSE:AMRX
Wall Street
Price Targets
AMRX Price Targets Summary
Amneal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AMRX
is 7.46 USD
with a low forecast of 6.31 USD and a high forecast of 8.4 USD.
AMRX Last Price Targets
Amneal Pharmaceuticals Inc
The latest public price target was made on Mar 21, 2024 by
David Amsellem
from
Piper Sandler
,
who expects
AMRX
stock to
rise by 47%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Amsellem
Piper Sandler
|
8
USD
Upside 47% |
4 weeks ago
Mar 21, 2024
|
Amneal Pharmaceuticals (AMRX) PT Raised to $8 at Piper Sandler
StreetInsider
|
Operating Income
Forecast
Operating Income Estimate
Amneal Pharmaceuticals Inc
For the last 8 years the
compound annual growth rate for
Amneal Pharmaceuticals Inc's operating income is
15%.
The projected
CAGR
for the next 3 years is
27%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMRX's stock price target?
Price Target
7.46
USD
According to Wall Street analysts, the average 1-year price target for
AMRX
is 7.46 USD
with a low forecast of 6.31 USD and a high forecast of 8.4 USD.
What is Amneal Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Amneal Pharmaceuticals Inc's revenue is
14%.
The projected
CAGR
for the next 3 years is
6%.
What is Amneal Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
27%
For the last 8 years the
compound annual growth rate for
Amneal Pharmaceuticals Inc's operating income is
15%.
The projected
CAGR
for the next 3 years is
27%.
You don't have any saved screeners yet
